Fox Run Management’s Sangamo Therapeutics SGMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-11,956
| Closed | -$59K | – | 854 |
|
|
2022
Q3 | $59K | Buy |
+11,956
| New | +$59K | 0.02% | 573 |
|
|
2021
Q3 | – | Sell |
-12,271
| Closed | -$147K | – | 597 |
|
|
2021
Q2 | $147K | Buy |
+12,271
| New | +$147K | 0.13% | 304 |
|
|
2018
Q3 | – | Sell |
-12,486
| Closed | -$177K | – | 793 |
|
|
2018
Q2 | $177K | Sell |
12,486
-12,425
| -50% | -$176K | 0.06% | 590 |
|
|
2018
Q1 | $473K | Sell |
24,911
-38,164
| -61% | -$725K | 0.11% | 331 |
|
|
2017
Q4 | $1.03M | Buy |
63,075
+49,175
| +354% | +$806K | 0.3% | 63 |
|
|
2017
Q3 | $209K | Sell |
13,900
-400
| -3% | -$6.01K | 0.06% | 593 |
|
|
2017
Q2 | $126K | Buy |
+14,300
| New | +$126K | 0.04% | 589 |
|